Prescriptions made by John ContI

Data for 2018

661

Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 67 providers in this state and specialty

$1.62M

Total Retail Price of All Prescriptions

Rank: 21 out of 67 providers in this state and specialty

130

Patients Receiving at Least One Drug in Part D

Rank: 21 out of 67 providers in this state and specialty

-

Average Risk Score

Not enough data available

75

Average Age of Patients

Average age of patients for providers in this state and specialty is 73

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Medical Oncology in New Jersey and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 LETROZOLE40
of 340
2210 prescriptions
Less than 1% of all prescriptions
2090480 patients
37% of all patients
< 11
2 EXEMESTANE60
of 200
410 prescriptions
Less than 1% of all prescriptions
410< 11< 11
3 TAMOXIFEN CITRATE150
of 270
240 prescriptions
Less than 1% of all prescriptions
130< 11< 11
4 PREDNISONE190
of 400
260 prescriptions
Less than 1% of all prescriptions
260< 11< 11
5 IMATINIB MESYLATE30
of 100
320 prescriptions
Less than 1% of all prescriptions
320< 11< 11
6 FENTANYL20
of 160
230 prescriptions
Less than 1% of all prescriptions
< 11< 11O
7 ANASTROZOLE380
of 410
120 prescriptions
Less than 1% of all prescriptions
< 11< 11
8 IMBRUVICA
(IBRUTINIB)
110
of 160
160 prescriptions
Less than 1% of all prescriptions
160< 11< 11
9 ZYTIGA
(ABIRATERONE ACETATE)
110
of 160
140 prescriptions
Less than 1% of all prescriptions
140< 11< 11
10 OPDIVO
(NIVOLUMAB)
20
of 20
140 prescriptions
Less than 1% of all prescriptions
140< 11< 11
11 WARFARIN SODIUM200
of 220
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
12 KEYTRUDA
(PEMBROLIZUMAB)
10
160 prescriptions
Less than 1% of all prescriptions
160< 11< 11
13 CABOMETYX
(CABOZANTINIB S-MALATE)
20
of 20
110 prescriptions
Less than 1% of all prescriptions
110< 11< 11
14 JAKAFI
(RUXOLITINIB PHOSPHATE)
90
of 130
110 prescriptions
Less than 1% of all prescriptions
110< 11< 11
15 ERIVEDGE
(VISMODEGIB)
10
110 prescriptions
Less than 1% of all prescriptions
110< 11< 11
16 IBRANCE
(PALBOCICLIB)
160
of 200
110 prescriptions
Less than 1% of all prescriptions
110< 11< 11
17 OXYCODONE-ACETAMINOPHEN
(OXYCODONE HCL/ACETAMINOPHEN)
80
of 190
200 prescriptions
Less than 1% of all prescriptions
200< 11< 11O